No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy

J Suzuki, Y Shimizu, K Tsuzuki, Z Pu… - American Journal …, 2021 - journals.physiology.org
Therapeutic angiogenesis with autologous stem/progenitor cells is a promising novel
strategy for treatment of severe ischemic diseases. Human clinical trials utilizing autologous …

No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy.

J Suzuki, Y Shimizu, K Tsuzuki, Z Pu… - American Journal of …, 2020 - europepmc.org
Therapeutic angiogenesis with autologous stem/progenitor cells is a promising novel
strategy for treatment of severe ischemic diseases. Human clinical trials utilizing autologous …

No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of 2 therapeutic angiogenesis with cell therapy 3

J Suzuki, Y Shimizu, K Tsuzuki, MD Fujikawa… - journals.physiology.org
In this study, we demonstrated that local injection of ADRCs can promote 65 angiogenesis in
response to tissue ischemia, without promoting remote tumor 66 growth in a mouse model …

No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy

J Suzuki, Y Shimizu, K Tsuzuki, Z Pu, S Narita… - American Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: p> In this study, we demonstrated that local injection of ADRCs can promote
angiogenesis in response to tissue ischemia without promoting remote tumor growth in a …

No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy

J Suzuki, Y Shimizu, K Tsuzuki, Z Pu… - American journal …, 2021 - pubmed.ncbi.nlm.nih.gov
Therapeutic angiogenesis with autologous stem/progenitor cells is a promising novel
strategy for treatment of severe ischemic diseases. Human clinical trials utilizing autologous …